In Vivo Team: Theo Hatzipetros, Ph.D.
Theo Hatzipetros, Ph.D., is an in vivo pharmacologist who joined ALS TDI in 2011 after working on
treatments in another neurodegenerative disease, Parkinson's. As Director of Pharmacology, Theo
oversees the execution of multiple studies of experimental drugs in ALS. He focuses on the
development of novel animal models of ALS and evaluating therapeutic strategies for the treatment of ALS.